OFM
Omega Fund Management Portfolio holdings
AUM
$154M
This Quarter Return
-9.1%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$138M
AUM Growth
+$138M
(-22%)
Cap. Flow
-$15.9M
Cap. Flow
% of AUM
-11.49%
Top 10 Holdings %
Top 10 Hldgs %
98.27%
Holding
12
New
1
Increased
–
Reduced
3
Closed
–
Top Buys
| 1 |
OBSV
ObsEva SA Ordinary Shares
OBSV
|
$9.76M |
Top Sells
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$14.7M |
| 2 |
FibroGen
FGEN
|
$8.71M |
| 3 |
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
|
$2.27M |
Sector Composition
| 1 | Healthcare | 73.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRTK
1
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $46.5M | 33.65% | 2,600,410 | – | – |
|
|
JUNO
2
DELISTED
Juno Therapeutics, Inc.
JUNO
| $34.4M | 24.9% | 753,564 -321,048 | -30% | -$14.7M |
|
|
SNNA
3
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
| $13.8M | 9.96% | 758,610 | – | – |
|
|
OBSV
4
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $9.76M | 7.06% | +1,000,000 | New | +$9.76M |
|
|
JNCE
5
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $7.39M | 5.34% | 579,650 | – | – |
|
|
PVLA
6
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $6.83M | 4.94% | 904,053 -300,000 | -25% | -$2.27M |
|
|
7
FibroGen
FGEN
$47.8M
| $6.19M | 4.48% | 130,646 -183,702 | -58% | -$8.71M |
|
|
CBAY
8
DELISTED
Cymabay Therapeutics
CBAY
| $5.07M | 3.67% | 551,477 | – | – |
|
9
Cidara Therapeutics
CDTX
$1.66B
| $3.03M | 2.19% | 444,965 | – | – |
|
|
EGLT
10
DELISTED
Egalet Corporation
EGLT
| $2.89M | 2.09% | 2,889,926 | – | – |
|
|
DRNA
11
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.02M | 1.46% | 223,457 | – | – |
|
12
ESSA Pharma
EPIX
$11.4M
| $373K | 0.27% | 1,696,969 | – | – |
|